BRTXMICRO

BioRestorative Therapies, Inc.

HealthcareBiotechnology
$0.37
$0.00(-6.19%)
52W$0.16
$1.89
Updated Jun 28, 02:00 AM
RSI56
RS Rating63/99
Beta2.07
Volatility140%
F-Score3/9
Mkt Cap$3M
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

BioRestorative Therapies, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 63), indicating performance broadly in line with the market. Earnings growth of 63% provides fundamental context to the price action. However, price is extended 24% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
63
out of 99
Average
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
2.07
vs S&P 500
HIGH BETA
52W Position
12%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$0.30
50 SMA > 100 SMA$0.32
100 SMA > 150 SMA$0.59
150 SMA > 200 SMA$0.82

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$0.39-5.47%BELOW
50 SMA$0.30+24.24%ABOVE
100 SMA$0.32+14.46%ABOVE
150 SMA$0.59-37.81%BELOW
200 SMA$0.82-54.93%BELOW

Price Performance

1D-6.2%
1W-9.6%
1M+48.0%
3M+24.9%
6M-67.0%
YTD-69.7%
1Y-77.9%
3Y-61.5%
52-Week Trading Range12% from low
$0.37
52W Low$0.16
52W High$1.89

Technical Indicators

RSI (14)NEUTRAL
55.9
305070
Setup ScoreCOOL
5/10
Base depth: 140.9%

Risk Profile

Beta
2.07
52W Vol
140%
ATR
$0.04
Max DD (1Y)
-91%

Volume Analysis

Today
50D Avg
13.17M
Vol Ratio
0.00x
Liquidity
MODERATE

Earnings Momentum

Q2'25+40%
$-0.30
Q3'25-154%
$-0.33
Q4'25-71%
$-0.36
Q1'26+63%
$-0.24
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:-5.43%
5 Years:+36.11%
3 Years:+44.27%
TTM:-8.47%

Compounded Profit Growth

10 Years:+58.15%
5 Years:
3 Years:
TTM:+16.89%

Stock Price CAGR

10 Years:-65.20%
5 Years:-57.92%
3 Years:-61.53%
1 Year:-77.87%

Return on Equity

10Y Avg:-208.0%
5Y Avg:-208.0%
3Y Avg:-173.3%
Last Year:-423.8%

Key Metrics

Market Cap$3M
Gross Margin93.4%
Net Margin-39.6%
Piotroski F-Score3/9

Frequently Asked Questions

Is BRTX in an uptrend right now?

BRTX has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is BRTX overbought or oversold?

BRTX's RSI (14) is 56. The stock is in neutral territory, neither overbought nor oversold.

Is BRTX outperforming the market?

BRTX has a Relative Strength (RS) Rating of 63 out of 99. BRTX is performing about average compared to the market.

Where is BRTX in its 52-week range?

BRTX is trading at $0.37, which is 20% of its 52-week high ($1.89) and 12% above its 52-week low ($0.16).

How volatile is BRTX?

BRTX has a Beta of 2.07 and 52-week volatility of 140%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.